| 2026-01-27 | +79.1% | news | TipRanks | Here’s Why Nuwellis Stock (NUWE) Rocketed Today - TipRanks |
| 2026-01-27 | +79.1% | legal | Benzinga | NUWE Stock: How This $2 Microcap Secured An Infant Healthcare Monopoly - Nuwellis (NASDAQ:NUWE) - Benzinga |
| 2026-01-27 | +79.1% | news | StocksToTrade | Nuwellis Receives New Patent: Stock Adjustments Follow - StocksToTrade |
| 2026-01-27 | +79.1% | news | Benzinga | Why Biomx Shares Are Trading Higher By Over 100%; Here Are 20 Stocks Moving Premarket - Benzinga |
| 2024-11-01 | +63.2% | earnings | Seeking Alpha | Nuwellis shares nearly doubled on higher than expected Q3 prelim revenue |
| 2024-11-01 | +63.2% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2024-05-07 | +52.8% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2024-11-05 | -46.4% | news | Seeking Alpha | Nuwellis tumbles on exercise of warrants to raise $5.1M |
| 2025-06-09 | -43.2% | news | Seeking Alpha | Nuwellis prices public offering of stock and warrants; shares down over 37% |
| 2025-06-09 | -43.2% | legal | SEC EDGAR | NUWE 8-K: 1.01, 3.02, 5.03 (SEC Filing) |
| 2025-06-09 | -43.2% | news | GuruFocus | Nuwellis (NUWE) Announces Stock Offering, Shares Plummet - GuruFocus |
| 2025-06-09 | -43.2% | news | Investing.com UK | Nuwellis announces pricing of public stock and warrants offering By Investing.com - Investing.com UK |
| 2024-05-01 | +39.4% | legal | SEC EDGAR | NUWE 8-K: 1.01, 8.01 (SEC Filing) |
| 2021-09-15 | -32.7% | news | AskTraders | Nuwellis (NUWE) Stock Slides On News Of Public Offering - AskTraders |
| 2023-05-09 | -29.9% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2024-11-15 | -23.3% | legal | Seeking Alpha | Nuwellis files for secondary stock offering |
| 2022-12-27 | +22.3% | legal | SEC EDGAR | NUWE 8-K: 8.01 and (SEC Filing) |
| 2024-03-05 | -21.2% | news | Stock Titan | Nuwellis, Inc. Announces Fourth Quarter and Full Year 2023 Financial Results - Stock Titan |
| 2022-10-03 | -20.6% | legal | SEC EDGAR | NUWE 8-K: 8.01 and (SEC Filing) |
| 2023-10-10 | -18.7% | legal | SEC EDGAR | NUWE 8-K: 8.01 and (SEC Filing) |
| 2024-08-23 | -17.7% | news | Seeking Alpha | Nuwellis to sell 496,901 shares at $1.845 in registered direct offering |
| 2024-12-16 | -17.0% | legal | SEC EDGAR | NUWE 8-K: 8.01 (SEC Filing) |
| 2024-08-13 | -16.3% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2021-11-09 | -16.0% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2024-11-08 | +15.9% | earnings | Seeking Alpha | Nuwellis Q3 Earnings Preview |
| 2022-12-29 | +15.4% | legal | SEC EDGAR | NUWE 8-K: 1.01 and (SEC Filing) |
| 2022-11-08 | -15.1% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2023-02-03 | +14.6% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Nuwellis (NUWE) - Zacks Investment Research |
| 2025-09-09 | -14.4% | legal | SEC EDGAR | NUWE 8-K: 8.01 (SEC Filing) |
| 2025-07-02 | -14.3% | executive | Seeking Alpha | Nuwellis appoints John Erb as CEO |
| 2025-07-02 | -14.3% | legal | SEC EDGAR | NUWE 8-K: 3.03, 5.02, 5.03 (SEC Filing) |
| 2024-03-26 | -14.0% | legal | SEC EDGAR | NUWE 8-K: 8.01 (SEC Filing) |
| 2022-05-18 | -14.0% | legal | SEC EDGAR | NUWE 8-K: 8.01 and (SEC Filing) |
| 2024-07-17 | -13.3% | legal | SEC EDGAR | NUWE 8-K: 8.01 and (SEC Filing) |
| 2024-07-17 | -13.3% | legal | SEC EDGAR | NUWE 8-K: 7.01, 8.01 (SEC Filing) |
| 2025-08-19 | -12.1% | M&A | Seeking Alpha | Nuwellis signs letter of intent to acquire Rendiatech |
| 2025-08-19 | -12.1% | legal | SEC EDGAR | NUWE 8-K: 8.01 (SEC Filing) |
| 2023-11-01 | -12.0% | legal | SEC EDGAR | NUWE 8-K: 5.02 and (SEC Filing) |
| 2025-08-15 | +12.0% | earnings | Yahoo Finance | Nuwellis Inc (NUWE) Q2 2025 Earnings Call Highlights: Strategic Shifts Amid Revenue Challenges - Yahoo Finance |
| 2021-05-11 | -11.6% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2025-09-18 | -11.5% | legal | SEC EDGAR | NUWE 8-K: 8.01 (SEC Filing) |
| 2022-10-06 | -11.3% | legal | SEC EDGAR | NUWE 8-K: 2.02 (SEC Filing) |
| 2021-05-12 | -11.2% | news | ChartMill | NUWE Technical Analysis | Trend, Signals & Chart Patterns | NUWELLIS INC (NASDAQ:NUWE) - ChartMill |
| 2024-11-07 | +11.2% | legal | SEC EDGAR | NUWE 8-K: 1.01, 3.02, 3.03, 8.01 (SEC Filing) |
| 2023-01-09 | -10.8% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2026-03-17 | -10.7% | M&A | GlobeNewswire | Nuwellis Completes Acquisition of Rendiatech |
| 2026-03-17 | -10.7% | legal | SEC EDGAR | NUWE 8-K: 8.01 (SEC Filing) |
| 2026-03-17 | -10.7% | news | Stock Titan | Nuwellis buys new kidney monitors to guide earlier care for sickest patients - Stock Titan |
| 2026-03-17 | -10.7% | M&A | Stock Titan | Nuwellis (NASDAQ: NUWE) closes deal for Rendiatech kidney monitoring tech - Stock Titan |
| 2026-03-08 | -10.7% | news | Seeking Alpha | Quant snapshot: Avino Silver & Gold, Harmony Gold lead strong buys as Angel Studios, Exagen lag |
| 2026-04-13 | +10.6% | earnings | UBND thành phố Hải Phòng | Is Nuwellis (NUWE) Stock a Value Play | NUWE Q4 Earnings: Beats Estimates by $0.09 - Pre Announcement - UBND thành phố Hải Phòng |
| 2022-10-18 | -10.5% | legal | SEC EDGAR | NUWE 8-K: 1.01, 3.03, 5.03, 8.01 (SEC Filing) |
| 2023-11-07 | -10.4% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2024-08-26 | +10.3% | legal | SEC EDGAR | NUWE 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2025-11-12 | -10.3% | earnings | Seeking Alpha | Nuwellis, Inc. (NUWE) Q3 2025 Earnings Call Prepared Remarks Transcript |
| 2025-11-12 | -10.3% | earnings | Seeking Alpha | Nuwellis GAAP EPS of $0.56, revenue of $2.22M |
| 2025-11-12 | -10.3% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2025-11-12 | -10.3% | earnings | Yahoo Finance | Nuwellis Inc (NUWE) Q3 2025 Earnings Call Highlights: Strong Sequential Growth Amid Revenue ... - Yahoo Finance |
| 2026-04-10 | +10.2% | news | Cổng thông tin điện tử tỉnh Tây Ninh | Does Nuwellis (NUWE) Stock pay reliable income | Price at $1.10, Up 1.85% - High Beta Stocks - Cổng thông tin điện tử tỉnh Tây Ninh |
| 2025-07-23 | -10.2% | legal | SEC EDGAR | NUWE 8-K: 8.01 (SEC Filing) |
| 2022-10-05 | +10.0% | legal | SEC EDGAR | NUWE 8-K: 5.02, 5.03 (SEC Filing) |
| 2026-03-09 | -9.8% | earnings | Seeking Alpha | Nuwellis Q4 Earnings Preview |
| 2025-09-30 | -9.8% | legal | SEC EDGAR | NUWE 8-K: 8.01 (SEC Filing) |
| 2025-10-08 | -9.7% | legal | SEC EDGAR | NUWE 8-K: 5.02 (SEC Filing) |
| 2021-08-10 | +9.3% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2022-04-21 | -8.8% | legal | SEC EDGAR | NUWE 8-K: 8.01 and (SEC Filing) |
| 2024-06-06 | -8.6% | legal | SEC EDGAR | NUWE 8-K: 1.01, 8.01 (SEC Filing) |
| 2021-06-22 | +8.4% | legal | SEC EDGAR | NUWE 8-K: 5.02, 7.01 (SEC Filing) |
| 2026-01-30 | -8.3% | executive | Seeking Alpha | Nuwellis appoints CFO |
| 2026-01-30 | -8.3% | legal | SEC EDGAR | NUWE 8-K: 1.01, 3.02, 3.03, 5.02, 7.01 (SEC Filing) |
| 2026-01-30 | -8.3% | executive | Investing.com | Nuwellis stock falls after CFO appointment announcement - Investing.com |
| 2026-01-30 | -8.3% | executive | marketscreener.com | Nuwellis, Inc. Appoints Carisa Schultz as Chief Financial Officer, Effective February 2, 2026 - marketscreener.com |
| 2026-01-30 | -8.3% | news | The Manila Times | Nuwellis Announces $5 Million Private Placement and Warrant Inducement Transaction, Priced At-The-Market - The Manila Times |
| 2026-02-26 | -8.0% | legal | SEC EDGAR | NUWE 8-K: 5.02, 7.01, 8.01 (SEC Filing) |
| 2025-07-17 | -7.7% | news | Investing.com | Nuwellis stock falls after company terminates REVERSE-HF clinical trial - Investing.com |
| 2026-04-08 | -7.6% | news | Xã Vĩnh Công | Should I Buy Nuwellis (NUWE) Stock in 2026 | Price at $1.14, Up 0.88% - Gap Down Stocks - Xã Vĩnh Công |
| 2025-02-24 | -7.5% | executive | Seeking Alpha | Nuwellis announces CEO retirement |
| 2025-02-24 | -7.5% | legal | SEC EDGAR | NUWE 8-K: 5.02, 7.01 (SEC Filing) |
| 2022-08-09 | -7.3% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2022-12-09 | -6.9% | legal | SEC EDGAR | NUWE 8-K: 5.02 and (SEC Filing) |
| 2024-11-11 | +6.8% | earnings | Seeking Alpha | Nuwellis, Inc. (NUWE) Q3 2024 Earnings Call Transcript |
| 2024-11-11 | +6.8% | earnings | Seeking Alpha | Nuwellis GAAP EPS of $1.74 beats by $3.02, revenue of $2.34M misses by $0.06M |
| 2022-09-08 | -6.7% | analyst | TradingView | NUWE Forecast — Price Target — Prediction for 2027 - TradingView |
| 2025-08-21 | -6.0% | legal | SEC EDGAR | NUWE 8-K: 8.01 (SEC Filing) |
| 2025-03-11 | -6.0% | earnings | Seeking Alpha | Nuwellis, Inc. (NUWE) Q4 2024 Earnings Call Transcript |
| 2025-03-11 | -6.0% | earnings | Seeking Alpha | Nuwellis GAAP EPS of -$0.44 misses by $0.01, revenue of $2.32M misses by $0.14M |
| 2025-03-11 | -6.0% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2023-01-18 | +6.0% | legal | SEC EDGAR | NUWE 8-K: 5.02 (SEC Filing) |
| 2021-05-20 | +5.9% | legal | SEC EDGAR | NUWE 8-K: 5.02, 5.07 (SEC Filing) |
| 2026-04-16 | -5.5% | news | GlobeNewswire | Nuwellis Welcomes Back Three Former Team Members to Accelerate Commercial and Clinical Momentum |
| 2026-04-16 | -5.5% | news | Stock Titan | Three former Nuwellis employees return as Aquadex expansion pushes on - Stock Titan |
| 2023-10-17 | -5.4% | legal | SEC EDGAR | NUWE 8-K: 1.01, 3.03, 5.03, 8.01 (SEC Filing) |
| 2024-02-06 | -5.3% | legal | SEC EDGAR | NUWE 8-K: 8.01 and (SEC Filing) |
| 2026-03-10 | +4.9% | earnings | Moby | Nuwellis, Inc. Q4 2025 Earnings Call Summary |
| 2026-03-10 | +4.9% | earnings | Motley Fool | Nuwellis (NUWE) Q4 2025 Earnings Call Transcript |
| 2026-03-10 | +4.9% | news | GlobeNewswire | Nuwellis, Inc. Announces Fourth Quarter and Full Year 2025 Financial Results |
| 2026-03-10 | +4.9% | earnings | Seeking Alpha | Nuwellis, Inc. (NUWE) Q4 2025 Earnings Call Transcript |
| 2026-03-10 | +4.9% | earnings | Seeking Alpha | Nuwellis GAAP EPS of -$1.50, revenue of $2.42M |
| 2026-03-10 | +4.9% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2026-03-10 | +4.9% | earnings | Stock Titan | Heart failure and pediatric growth lift Nuwellis Q4 as console demand jumps 208% - Stock Titan |
| 2026-03-18 | -4.8% | M&A | The Globe and Mail | Nuwellis Completes Acquisition of Kidney Monitoring Innovator Rendiatech - The Globe and Mail |
| 2023-06-05 | +4.7% | legal | SEC EDGAR | NUWE 8-K: 5.02 and (SEC Filing) |
| 2025-05-14 | -4.6% | news | Intellectia AI | NUWE Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI |
| 2024-11-12 | -4.6% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2025-09-03 | -4.6% | legal | SEC EDGAR | NUWE 8-K: 1.01 and (SEC Filing) |
| 2023-08-18 | -4.4% | legal | SEC EDGAR | NUWE 8-K: 5.02 and (SEC Filing) |
| 2024-07-25 | -4.2% | legal | SEC EDGAR | NUWE 8-K: 1.01, 3.02, 7.01 (SEC Filing) |
| 2021-11-23 | +4.1% | legal | SEC EDGAR | NUWE 8-K: 1.01 and (SEC Filing) |
| 2023-08-08 | -4.0% | legal | SEC EDGAR | NUWE 8-K: 5.02, 7.01 (SEC Filing) |
| 2023-08-08 | -4.0% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2025-05-13 | -3.8% | earnings | Seeking Alpha | Nuwellis, Inc. (NUWE) Q1 2025 Earnings Call Transcript |
| 2025-05-13 | -3.8% | earnings | Seeking Alpha | Nuwellis GAAP EPS of -$0.69 misses by $0.24, revenue of $1.9M misses by $0.6M |
| 2025-05-13 | -3.8% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2023-06-21 | -3.6% | legal | SEC EDGAR | NUWE 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2026-04-07 | -3.5% | news | GlobeNewswire | Nuwellis Strengthens Commercial Infrastructure with New South Texas Territory |
| 2026-04-07 | -3.5% | news | Stock Titan | South Texas hospitals get dedicated Nuwellis team for fluid care - Stock Titan |
| 2024-03-06 | -3.5% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2025-03-10 | -3.5% | earnings | Seeking Alpha | Nuwellis Q4 Earnings Preview |
| 2023-03-01 | +3.1% | legal | SEC EDGAR | NUWE 8-K: 2.02, 8.01 (SEC Filing) |
| 2022-11-30 | -3.1% | legal | SEC EDGAR | NUWE 8-K: 3.01, 8.01 (SEC Filing) |
| 2021-05-02 | +3.0% | earnings | MarketBeat | Nuwellis (NUWE) Stock Price, News & Analysis $NUWE - MarketBeat |
| 2025-05-12 | -3.0% | earnings | Seeking Alpha | Nuwellis Q1 Earnings Preview |
| 2025-05-12 | -3.0% | legal | SEC EDGAR | NUWE 8-K: 1.01 and (SEC Filing) |
| 2026-04-01 | +3.0% | legal | SEC EDGAR | NUWE 8-K: 5.02 and (SEC Filing) |
| 2026-04-01 | +3.0% | news | Stock Titan | Former Nuwellis (NASDAQ: NUWE) directors submit response letters - Stock Titan |
| 2022-05-10 | +2.8% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2022-09-23 | +2.6% | legal | SEC EDGAR | NUWE 8-K: 5.02 (SEC Filing) |
| 2026-03-27 | -2.5% | legal | SEC EDGAR | NUWE 8-K: 5.02 and (SEC Filing) |
| 2026-03-27 | -2.5% | executive | TipRanks | Nuwellis Board Directors Resign Amid Governance Dispute - TipRanks |
| 2026-04-23 | +2.2% | news | GlobeNewswire | Nuwellis to Participate in the AATS 106th Annual Meeting and ERAS Cardiac Spring Retreat |
| 2026-04-23 | +2.2% | news | Stock Titan | Chicago heart-surgery meeting puts Nuwellis' fluid-removal system on display - Stock Titan |
| 2026-01-29 | -1.8% | M&A | Seeking Alpha | Nuwellis to acquire Rendiatech, raises $5 mln in private placement |
| 2025-11-11 | -1.8% | earnings | Seeking Alpha | Nuwellis Q3 Earnings Preview |
| 2026-04-20 | -1.7% | news | ChartMill | NUWE Stock Price, Quote & Chart | NUWELLIS INC (NASDAQ:NUWE) - ChartMill |
| 2026-04-18 | -1.5% | news | UBND thành phố Hải Phòng | Nuwellis (NUWE) Stock: Trending Down? (Volatility Increases) 2026-04-18 - Professional Trade Ideas - UBND thành phố Hải Phòng |
| 2024-02-12 | +1.4% | news | CNN | symbol__ Stock Quote Price and Forecast - CNN |
| 2024-05-29 | +1.4% | legal | SEC EDGAR | NUWE 8-K: 3.01 and 8.01 (SEC Filing) |
| 2022-03-01 | -1.3% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2026-04-21 | -1.2% | news | GlobeNewswire | Nuwellis Announces Aquadex Software Update |
| 2026-04-21 | -1.2% | earnings | Stock Titan | Nuwellis halves Aquadex fluid-adjustment steps for pediatric patients - Stock Titan |
| 2025-08-14 | +1.0% | earnings | Seeking Alpha | Nuwellis outlines Q3 recovery and strategic shift after resolving $400,000 back order |
| 2025-08-14 | +1.0% | earnings | Seeking Alpha | Nuwellis, Inc. (NUWE) Q2 2025 Earnings Call Transcript |
| 2025-08-14 | +1.0% | earnings | Seeking Alpha | Nuwellis GAAP EPS of -$60.99, revenue of $1.73M |
| 2025-08-14 | +1.0% | legal | SEC EDGAR | NUWE 8-K: 2.02 and (SEC Filing) |
| 2026-01-23 | +0.9% | legal | SEC EDGAR | NUWE 8-K: 5.02, 7.01 (SEC Filing) |
| 2024-12-19 | -0.8% | news | Seeking Alpha | Nuwellis regains compliance with Nasdaq listing requirements |
| 2024-12-19 | -0.8% | legal | SEC EDGAR | NUWE 8-K: 8.01 and (SEC Filing) |
| 2026-04-02 | -0.6% | legal | Stock Titan | [ARS] Nuwellis, Inc. SEC Filing - Stock Titan |
| 2021-04-30 | -0.5% | analyst | eToro | Nuwellis Inc (NUWE) Stock Price, News & Analyst Forecast - eToro |
| 2026-04-09 | +0.4% | news | GlobeNewswire | Nuwellis Engages CORE IR for Public Relations, Shareholder Communications, and Social Media Management Services |
| 2026-04-09 | +0.4% | news | Cổng thông tin điện tử Tỉnh Sơn La | Is Nuwellis (NUWE) Stock Overpriced Now | Price at $1.10, Up 1.85% - Market Hype Signals - Cổng thông tin điện tử Tỉnh Sơn La |
| 2026-04-09 | +0.4% | news | Stock Titan | Nuwellis brings in CORE IR to sharpen investor outreach and social media - Stock Titan |
| 2021-09-17 | +0.1% | legal | SEC EDGAR | NUWE 8-K: 1.01, 8.01 (SEC Filing) |
| 2026-03-31 | +0.1% | earnings | GlobeNewswire | Nuwellis Pediatric Category Achieves Approximately 50% of Total U.S. Revenue in 2025, Marking Growth Milestone |
| 2026-03-31 | +0.1% | earnings | Stock Titan | Half of Nuwellis U.S. revenue now comes from pediatric care - Stock Titan |
| 2022-12-08 | -0.0% | legal | SEC EDGAR | NUWE 8-K: 5.07, 8.01 (SEC Filing) |
| 2026-04-24 | — | legal | SEC EDGAR | NUWE 8-K: 8.01 (SEC Filing) |
| 2026-04-24 | — | legal | Stock Titan | Nuwellis (NUWE) to pay $204,000 to settle E.F. Hutton lawsuit - Stock Titan |
| 2026-04-24 | — | news | MEXC Exchange | NUWE Price Today: Nuwellis, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange |